Results 141 to 150 of about 2,007,940 (182)
Acceptability and Use of Digital Health and Artificial Intelligence-Enabled Chatbots for Sexual and Reproductive Health Among Lesbian, Bisexual, and Queer Women of Color in the United States: Cross-Sectional Survey Study. [PDF]
J Med Internet ResThreats M, Gray M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
U.S. Women Need the Dapivirine Ring, Too: FDA as Structural Barrier to HIV Prevention for Women
AIDS Education and Prevention, 2022The dapivirine monthly vaginal ring-a discreet, anti-HIV microbicide created specifically for women-has received a positive scientific opinion by the European Medicines Agency and is included in the WHO HIV prevention guidelines.
Erica Gollub
exaly +2 more sources
Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention
AIDS and Behavior, 2021Understanding characteristics associated with adherence to pre-exposure prophylaxis (PrEP) methods for HIV-1 prevention may assist with optimizing implementation efforts. The dapivirine vaginal ring is a novel topical PrEP delivery method. Using data from a randomized, double-blind, placebo-controlled, phase III trial of the dapivirine vaginal ring ...
Jared M Baeten +2 more
exaly +3 more sources
AIDS and Behavior, 2021
We analyzed data from 1428 users of the dapivirine vaginal ring, who participated in the MTN-020/ASPIRE phase III trial and subsequent open-label extension MTN-025/HOPE trial, to examine relationships between perceived ring protection, social disclosures, and self-reported ring adherence. In HOPE, 77% perceived the ring to be highly effective, and this
Ariane van der Straten +2 more
exaly +3 more sources
We analyzed data from 1428 users of the dapivirine vaginal ring, who participated in the MTN-020/ASPIRE phase III trial and subsequent open-label extension MTN-025/HOPE trial, to examine relationships between perceived ring protection, social disclosures, and self-reported ring adherence. In HOPE, 77% perceived the ring to be highly effective, and this
Ariane van der Straten +2 more
exaly +3 more sources
Development of dapivirine vaginal ring for HIV prevention
Antiviral Research, 2013In the continuing effort to develop effective HIV prevention methods for women, a vaginal ring containing the non-nucleoside reverse transcriptase inhibitor dapivirine is currently being tested in two safety and efficacy trials. This paper reviews dapivirine ring's pipeline development process, including efforts to determine safe and effective dosing ...
Jeremy Nuttall +2 more
exaly +3 more sources
Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring
AIDS Research and Human Retroviruses, 2009 Vaginal delivery of 200 mg or 25 mg dapivirine from intravaginal rings (IVRs) was evaluated over a 7-day period in two phase 1 safety trials (IPM001 and IPM008, respectively) in a total of 25 healthy women 19 to 46 years of age. The IVR was generally safe and well tolerated with similar adverse events observed in the placebo and dapivirine groups ...
Romano, J. +10 more
openaire +4 more sources